Merus N.V. (MRUS): Price and Financial Metrics
MRUS Price/Volume Stats
| Current price | $39.45 | 52-week high | $61.61 |
| Prev. close | $39.65 | 52-week low | $31.27 |
| Day low | $38.71 | Volume | 638,900 |
| Day high | $40.12 | Avg. volume | 793,364 |
| 50-day MA | $44.67 | Dividend yield | N/A |
| 200-day MA | $49.15 | Market Cap | 2.70B |
MRUS Stock Price Chart Interactive Chart >
Merus N.V. (MRUS) Company Bio
Merus B.V., a clinical-stage immuno-oncology company, engages in developing bispecific antibody therapeutics. The company was founded in 2003 and is based in Utrecht, Netherlands.
MRUS Price Returns
| 1-mo | -5.73% |
| 3-mo | -24.58% |
| 6-mo | -27.37% |
| 1-year | 13.10% |
| 3-year | 52.32% |
| 5-year | 133.43% |
| YTD | -6.18% |
| 2024 | 52.91% |
| 2023 | 77.76% |
| 2022 | -51.35% |
| 2021 | 81.40% |
| 2020 | 24.50% |
Continue Researching MRUS
Want to see what other sources are saying about Merus NV's financials and stock price? Try the links below:Merus NV (MRUS) Stock Price | Nasdaq
Merus NV (MRUS) Stock Quote, History and News - Yahoo Finance
Merus NV (MRUS) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...